{"disease":{"id":"controlled-ovarian-hyperstimulation","name":"controlled ovarian hyperstimulation"},"drugs":{"marketed":[{"drug_id":"ganirelix","indication_name":"Prevention of Luteinizing Hormone Surge when undergoing Controlled Ovarian Hyperstimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ganirelix Acetate","generic_name":"GANIRELIX","company_name":"Organon Usa Organon","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"Gonadotropin Releasing Hormone Receptor Antagonist","quality_score":46,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05994378","title":"To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":317,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT02738580","title":"Follicular Steroid Genesis in Controlled Ovarian Stimulation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Instituto Valenciano de Infertilidad, IVI VALENCIA","has_results":true},{"nct_id":"NCT06812559","title":"Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"El Shatby University Hospital for Obstetrics and Gynecology","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}